Scancell Share Discussion Threads

[ivyspivey] 17/3/2019 18:07

It is your choice to respond or not.I was only seeking to engage and not dictate but no matter.

I won’t sell this level either and like you value the IP much higher.But I am not happy as I could have twice as many shares if I had bought at this price,I don’t like being well underwater,even though I can happily wait for many more years and I recognise the risks of having to raise at a low share price

Anyway it may be a big Easter Bunny out of the hat may be the only thing that makes us all happy

[inanaco] 17/3/2019 17:47

No Ivy ..

just because you ask i don't have to reply ...

you ask "am i happy with the share price .. ""

Don't really care chap ... low share price = buy it has benefits but not if you want to sell

I hold for deals based on how I value the IP ...

How you value it ? or the share price i really don't care because i would not sell at this level

so i am not concerned the share price is at this level .. as i explained to Gazza he understood

why can't you ?

[ivyspivey] 17/3/2019 17:41

Once again Inanaco several of us give you the opportunity to debate without any personal attacks but you continue to avoid answering any of our questions/ respond to irrelevant focus on the minutiae of the science/make oblique references which no one else understands and plenty other stuff rather than just respond in a reasonable way.

You really don’t prove anything whereas you would earn much more respect if you engaged with people in a rationale way rather than constantly take an opposing view on everything and to everyone.

I know I will get the usual dismissive response from you like sell it all.Well as BS says that is a decision for us as individuals at our time of choosing.

You claim we are all moaners when we imo just pose reasonable questions of the BOD.
As you refuse to answer my question of are you happy with the current share price I can only presume that with twice as many shares as me and a much higher average you must be feeling even more u happy than I am.

If on the other hand you are happy with current state of affairs then you must be in a minority on one

[inanaco] 17/3/2019 17:19

not arguing with Knowlesi .. he is a BUYER of scancell ... i proved it

sorry you have issues ...

better luck next time

[inanaco] 17/3/2019 17:08

ONW if provenge was so fantastic why is it not available on the NHS ?

hxxps://www.sps.nhs.uk/medicines/sipuleucel-t/

[oldnotwise] 17/3/2019 17:03

Bermuda
I'm afraid logic (or often the truth) seems to have no part of Inanacos' world. If he's losing an argument anything's pulled into the arena.... and I mean anything to deflect.
Why? It's simple he's so far away from the real world (IMO) that I really don't think he's capable of "owning up" when cornered. In fact I think he genuinely believes he's always right.
At least that's what i've noticed over the last seven years or so....
Sad really, but I'm just grateful that I do know when I should 'fess up.
Never mind, I've certainly got better things to do.
I should have known better..
:-)
ATB

[inanaco] 17/3/2019 17:03

can you please confirm that The NHS has approved Provenge ?

[bermudashorts] 17/3/2019 17:00

Nope, I got the point perfectly thanks. Trash another drug with the aim of giving the impression of validating your valuation for Scancell.

[inanaco] 17/3/2019 16:50

provenge approved value of dendroen went to $7.5 billion

scancell macp .. £20m ....

i think you have missed the point

[inanaco] 17/3/2019 16:48

has Nice approved it ?

[bermudashorts] 17/3/2019 16:40

The reason you won't answer my question is because you can't - Scancell haven't run any randomised trials, so you can't tell me the overall survival for the patients with tumour in situ. That's the difference between a drug that has been through phase III trials and received FDA approval and a phase IIa candidate and precisely why you can't make comparisons. That is the point I have been trying to make.

[inanaco] 17/3/2019 16:30

but you have implied you are an expert on provenge why do you now need my input of SCIB1

the issue with scancells data you cannot calculate an overall survival average as the majority are still alive .. your post does not make sense

[bermudashorts] 17/3/2019 16:25

well perhaps you can tell me what you think Scancell's efficacy is then, what is the increase in overall survival for the 15 SCIB1 melanoma patients with cancer in situ?

[inanaco] 17/3/2019 16:21

bermudashorts

Scancell is aiming higher without spending $1.2 billion

which AIM may have issue with

so if Scancell efficacy was only 20% i would start adding a far higher risk element to the trials ...

from a "Walk in the park"

to ... maybe

[inanaco] 17/3/2019 16:18

bermuda

""" On the one hand you tell us that you're an expert """

never seen that post ? ... it's more about degree's of ignorance on the subject some are more ignorant that others

the expert can only be Lindy ..

[inanaco] 17/3/2019 16:07

Efficacy

How was the efficacy of PROVENGE established?

The effectiveness of PROVENGE was studied in 512 patients with metastatic castrate resistant (hormone refractory) prostate cancer in a randomized, double-blind, placebo-controlled, multicenter trial. The study showed an increase in overall survival of approximately 4 months for patients receiving PROVENGE treatments as compared to the control group.

hxxps://www.fda.gov/biologicsbloodvaccines/cellulargenetherapyproducts/approvedproducts/ucm210037.htm

[inanaco] 17/3/2019 16:04

i can compare trial efficacy

indeed Scancell has managed it ...

otherwise no point having a phase 2 trial and placing any value on the data

[inanaco] 17/3/2019 15:50

The issue with moaning while holding Bermuda and playing the blame game it is not really reflective of the true position ..

because i can easily go back in your history and find posts on why vaccines went out of fashion etc .. which flies straight in the face of ONW's posts

point is the share price has decided this is the price and your moaning is priced in ...

do you consider it cheap enough to ignore the criticism and buy

or you would not sell because you feel the share price does not reflect the IP
then if you have the confidence you would be positive poster not negative

the issue of sentiment like pushing a future fund raise as inevitable that also flies in the face of why Tosh is holding ... ie a deal

so this constant switching to moan v BOOOOM is at best confusing

at least i am confident it will boooooooom and confident in failure due to funding issues that scancell putting itself up for sale will yield a higher return than the current share price just on the data that is presented